Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Polar Capital Biotechnology Class I - Income (USD)

Sell:1,960.14p Buy:1,960.14p Change: 2.41p (0.12%)
Prices as at 16 July 2019
Sell:1,960.14p
Buy:1,960.14p
Change: 2.41p (0.12%)
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account
Prices as at 16 July 2019
Sell:1,960.14p
Buy:1,960.14p
Change: 2.41p (0.12%)
Prices as at 16 July 2019
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Charges and Savings

Initial charges
Initial charge: 0.00%
Initial saving from HL: 0.00%
HL dealing charge: Free
Net initial charge: 0.00%
Annual charges
Performance fee: Yes   View risks
Ongoing charge (OCF/TER): 1.17%
Ongoing saving from HL: 0.00%
Net ongoing charge: 1.17%
There are other unit types of this fund available:
Class I - Income (GBP) (Net ongoing charge 1.17%)
Class I - Income (GBP Hedged) (Net ongoing charge 1.21%)

In some cases the ongoing savings are provided by our loyalty bonus. Loyalty bonuses are tax-free in an ISA or SIPP. However, they may be subject to tax in a Fund & Share Account which would, in effect, reduce their value and increase the net ongoing charge.


Other Information

Unit type: Unbundled
Manager:
David Pinniger
Fund launch date: 1 November 2013
Sector: Specialist
Fund size: £497 million
Number of holdings: 49
Fund type: OEIC
Accumulation/income: Income
Dealing frequency: Daily
Valuation point: 23:59
Trustee: Northern Trust Fiduciary Services (Ireland) Limited
Minimum investment: £100.00
Charges deducted from: Income
Available in a regular savings plan: Yes
Minimum regular savings value: £25.00

Performance

17/07/14 to 17/07/15 17/07/15 to 17/07/16 17/07/16 to 17/07/17 17/07/17 to 17/07/18 17/07/18 to 17/07/19
Annual return 85.80% -11.91% 32.44% 22.73% -0.01%

Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.

View fund chart

Our view on this fund

The Wealth 50 is the list of what we believe are the best funds in each sector. If a fund is not within our Wealth 50 this is not necessarily a recommendation to sell. However, if you are thinking of adding to your investments we believe Wealth 50 funds are superior alternatives. View funds on the Wealth 50 »

Fund Objective

The investment objective of the Polar Capital Biotechnology Fund is to achieve long-term capital growth by investing in a globally diversified portfolio of biotechnology companies.

Income Details

Income paid: Annually
Type of payment: Dividend
Ex-dividend date: 1 January 2020
Payment date: 31 May 20204

This data is provided by Funds Library. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision. All yields are variable and not guaranteed. There is currently no yield information available for this fund.

Sector Weight
Pharmaceuticals,Biotechnology & Marijuana Producers 77.64%
Cash and Equiv. 17.84%
Medical Equipment & Services 2.61%
Non-Classified 1.87%
Software & Computer Services 0.05%
Country Weight
United States 53.72%
Cash and Equiv. 17.84%
Belgium 7.46%
Germany 7.06%
United Kingdom 5.43%
Denmark 5.22%
Japan 2.56%
Italy 0.35%
Australia 0.20%
Canada 0.12%

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Morningstar, correct as at 16 July 2019. Data provided by Funds Library, correct as at 31 May 2019.

FundsLibrary
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account

4 If you elect to receive the income from a Vantage ISA or Vantage Fund & Share Account, we will collect any dividends for you and then pay them directly into your bank account within the first 10 working days of the following month.